[Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
D000328:Adult; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D005475:Flupenthixol / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010546:Perphenazine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D013892:Thioxanthenes / Q000008:administration & dosage*
D003692:Delayed-Action Preparations; D013892:Thioxanthenes; D005475:Flupenthixol; D010546:Perphenazine
Doppelblindvergleich von 2 Depotneuroleptika (Perphenazin-önanthat und Flupentixol-decanoat) bei chronischer Schizophrenie.